Bloomberg
TV Networks Tackle Declining Ad Sales
Jul.12 -- TV networks including ESPN are bracing for a drop in advertising revenue for football games in the coming season, which could drag down sales growth for sports broadcasts overall, advertising and television executives say....
Curated Video
Parkinson's disease - a journey through a brain
UK PARKINSON'S BRAINSOURCE: ASSOCIATED PRESSRESTRICTIONS: AP CLIENTS ONLYLENGTH: 6.12SHOTLIST:Associated Press London, UK - 6 March 20171. Close of complete brain of former Parkinson's patient 2. Various of pathologist Professor Steve...
Curated Video
The Long Road To Legalized Marijuana
How did marijuana get so widely accepted in the U.S., and where is it headed from here?
Curated Video
Marijuana Laws Are Changing. Will DUI Laws Follow?
There is little agreement or clarity on what the level of driving impairment is for marijuana, though the idea is mentioned by lawmakers.
Sky News
Babies Born Hooked On Heroin: Special Report
VOICED: New figures suggest the number of babies born addicted to narcotics in the United States has quadrupled in the last decade. Sky News has visited a hospital in Indiana which specialises in treating infants who become dependent on...
Bridgeman Arts
RESEARCH IMW TAPE 160 Army Hospital, drug use.
10:18:07:00 US Patient is helped to walk by a male and a female nurse, as he is suffering from a type of hysteria. 10:18:42:00 Patient with the hysterical paralysis is interviewed - then treatment starts with an injection 10:20:46:00 US...
Curated Video
What You Need To Know About The FDA-Approved Drug For Alzheimer's
Questions linger about whether treatment actually works. FDA will monitor the drug's effectiveness.
Curated Video
USA: FEDERAL AGENTS BREAK UP MEXICAN COLOMBIAN COCAINE RING
English/Nat
Federal agents in the US have arrested dozens of people to complete the break-up of a Mexican-Colombian cocaine ring.
The operation, codenamed Zorro II, began last September and over 150 people have been arrested across the...
Bloomberg
Ascletis Pharma CEO on IPO Performance, New Drugs, Revenue Targets
Jan.17 -- Jason Wu, chairman and chief executive officer at Ascletis Pharma, discusses the company's performance since the IPO, their new drugs coming to market, competition in the industry, regulatory approvals, drug prices, revenue...
Sky News
The RFU is to publish its annual review of anti-doping measures on Thursday.
The RFU is to publish its annual review of anti-doping measures on Thursday.
Bloomberg
Europe Set for Tighter Restrictions as Omicron Spreads
Europe's biggest countries are weighing more curbs to fight a surge in Covid-19 infections. From a new lockdown in the Netherlands to travel restrictions targeted by several countries at the U.K., the region faces a critical week of...
Curated Video
FDA Announces Coronavirus-Related Drug Shortage
A drug manufacturer tells the FDA coronavirus has caused shortages in a drug that's sold in the U.S.
Curated Video
DEA Warning Public About Counterfeit Pills Laced With Fentanyl
The DEA says Mexican cartels are making "mass quantities" of counterfeit prescription drugs laced with fentanyl for distribution in North America.
Curated Video
How Coronavirus Could Slow Down The U.S. Drug Supply
The United States relies on overseas factories for some of the key ingredients of vital medications, and shortages could impact medication supplies.
Sky News
Breakthrough for thoase at risk of Breast Cancer
Breakthrough for thoase at risk of Breast Cancer
Curated Video
Johnny Depp Was A Controlling Lover, Ex-Girlfriend Testifies
Ellen Barkin said that Depp often asked her where she was going and who she was with.
AFP News Agency
VOICED : Senegalese app fights medicine waste and fakes
Senegal is a country where many lack access to medicine and yet perfectly good drugs are going to waste
Bloomberg
Sage CEO Planning to Launch New Postpartum Drug in 2019
Jan.07 -- Sage Therapeutics Chief Executive Officer Jeff Jonas discusses the biotechnology company’s experimental antidepressant drug with Bloomberg's Taylor Riggs on "Bloomberg Markets: European Close."
Bloomberg
Covid-19 Has Many Months, Variants to Go: Johns Hopkins
Johns Hopkins Center for Health Security Senior Scholar Gigi Gronvall discusses the spread of the omicron variant, stress on the U.S. health care system, and the increase of antibodies from Covid-19 vaccines. The Bloomberg School of...
Curated Video
Modeled after the way plants cells expand and shrink in the sun, bioengineers at UC Berkeley have created a new gel that can be manipulated by light, which could be used for drug delivery and tissue engineering.
HEADLINE: Bioengineers invent light-controlled gel
Suggested Caption: Modeled after the way plants cells expand and shrink in the sun, bioengineers at UC Berkeley have created a new gel that can be manipulated by light, which could be...
Bloomberg
Gilead's Hepatitis C Drug Approved by FDA
June 28 -- Gilead's hepatitis C drug was approved by U.S. regulators for all forms of the viral disease, making it the first treatment with such a comprehensive label. Bloomberg Intelligence's Asthika Goonewardene has more on "Bloomberg...
AFP News Agency
CLEAN : Singapore court dismisses mentally disabled man's death sentence appeal
Singapore's top court Tuesday dismissed a mentally disabled Malaysian man's last-ditch appeal against a death sentence (Footage by AFPTV via Getty Images)
Curated Video
Dr. Charles Arntzen, Director of the Biodesign Institute at ASU talks about his research that focuses on genetically modifying tobacco plants to create a protein used to develop an Ebola drug. (Aug. 18)
Drug makers and academic laboratories going beyond standard techniques in the push to develop a treatment for the Ebola virus that's killed more than 1,100 people in West Africa.
Researchers working on the experimental drug ZMapp have...
Bloomberg
RemeGen CEO on H.K. IPO, Strategy, Drugs in Pipeline
Nov.08 -- Fang Jianmin, co-founder and chief executive officer of RemeGen Co., discusses the Chinese biotechnology company's initial public offering, strategy, and the drugs in its pipeline. RemeGen jumped more than 30 percent on its...